Entero Healthcare Solutions Limited Share Price & Stock Analysis

Entero Healthcare Solutions Limited (NSE: ENTERO, BSE: 544122) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹8,733 Cr, it ranks #639 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 13 in Pharmaceutical Product Distribution. At ₹1,976.00 (as of 16 Nov 2026), the share price is 7.6% below its 52-week high of ₹2,137.60 and 109.3% above its 52-week low of ₹944.00. The share price is up 80.7% over one year and up 36.0% over three months.

Key Metrics

Current Price₹1,976.00
Market Cap₹8,733 Cr
NSE SymbolENTERO
BSE Code544122
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Distributors > Pharmaceutical Product Distribution
P/E Ratio74.6
Return on Equity8.28%
Return on Assets4.41%
52-Week Range₹944.00 – ₹2,137.60
1-Year Price Change+80.7%
3-Month Price Change+36.0%
Beta (1Y)-0.09
HeadquartersMumbai, Maharashtra
Websitewww.enterohealthcare.com

Latest Quarterly Results — Q2 FY27

Revenue₹2,087 Cr
Net Profit₹61 Cr
Net Margin2.9%
EPS (Basic)₹10.47
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Entero Healthcare Solutions Limited Quarterly Revenue and Profit Trend

Entero Healthcare Solutions Limited reported revenue of ₹2,087 Cr in Q2 FY27, up 32.9% from ₹1,571 Cr in Q2 FY26 and up 7.6% from ₹1,941 Cr in Q1 FY27. It posted a net profit of ₹61 Cr for the quarter, against a net profit of ₹37 Cr in Q2 FY26 (up 66.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹1,339 Cr (Q4 FY25) to ₹2,087 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹2,087 Cr₹61 Cr2.9%
Q1 FY27₹1,941 Cr₹52 Cr2.7%
Q4 FY26₹1,910 Cr₹45 Cr2.4%
Q3 FY26₹1,707 Cr₹34 Cr2.0%
Q2 FY26₹1,571 Cr₹37 Cr2.3%
Q1 FY26₹1,404 Cr₹30 Cr2.2%
Q4 FY25₹1,339 Cr₹31 Cr2.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 52.40% of Entero Healthcare Solutions Limited's shares as of Sept 2026, against 52.42% in Sept 2025 (−0.02 percentage points). Delivery averaged 45.4% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Entero Healthcare Solutions Limited

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label products under the Entero Surgicals private label, such as monitoring devices, nursing and rehabilitation products, and consumables; commercial solutions; and healthcare product distribution solutions, including imports, central warehousing, redistribution, last mile delivery, and connection with the pharmacies, hospitals, and clinics. The company was incorporated in 2018 and is based in Mumbai, India.

Products and Services

1. Trading of Pharmaceutical and Surgical Products-This segment engages in the trading of pharmaceutical and surgical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Trading of Pharmaceutical and Surgical Products-100%

Entero Healthcare Solutions Limited vs Peers — Pharmaceutical Product Distribution

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Entero Healthcare Solutions Limited₹8,733 Cr74.68.28%₹2,087 Cr+80.7%
Remus Pharmaceuticals Limited₹941 Cr26.113.78%—+0.6%
Health X Platform Limited (Sastasundar Ventures Ltd)₹871 Cr752.7-0.18%₹484 Cr-5.7%
Aptus Pharma Limited₹837 Cr156.8——+754.0%
Vasa Denticity Limited₹797 Cr76.56.68%₹87 Cr-21.4%
Bijoy Hans Ltd₹523 Cr———+128.4%
Speciality Medicines Limited₹149 Cr11.5———
Vijaypd Ceutical Limited₹136 Cr239.53%——
Royal Sense Limited₹39 Cr5.6——-71.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited is trading at ₹1,976.00, with a market capitalisation of ₹8,733 Cr.

Which sector does Entero Healthcare Solutions Limited belong to?

Entero Healthcare Solutions Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).

What are the key financial ratios of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited has a P/E of 74.6 and a return on equity of 8.28%.

What is the stock symbol of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited is listed on the NSE under the symbol ENTERO and on the BSE under the scrip code 544122.

How has Entero Healthcare Solutions Limited's share price moved over the past year?

Entero Healthcare Solutions Limited's share price is up 80.7% over one year and up 36.0% over three months. Its 52-week range is ₹944.00 to ₹2,137.60.

What were Entero Healthcare Solutions Limited's latest quarterly results?

In Q2 FY27, Entero Healthcare Solutions Limited reported revenue of ₹2,087 Cr and net profit of ₹61 Cr, with basic EPS of ₹10.47 (consolidated, parsed from the company's exchange filing).

How have Entero Healthcare Solutions Limited's revenue and profit changed over the past year?

Entero Healthcare Solutions Limited reported revenue of ₹2,087 Cr in Q2 FY27, up 32.9% from ₹1,571 Cr in Q2 FY26 and up 7.6% from ₹1,941 Cr in Q1 FY27.

What is the promoter holding in Entero Healthcare Solutions Limited?

Promoters held 52.40% of Entero Healthcare Solutions Limited's shares as of Sept 2026, against 52.42% in Sept 2025 (−0.02 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.